×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 4: Special Topics
Session Chair(s)
Colin D'Cunha, MD, MHS, FRCPC
Director, Global Medical Affairs
Apotex Inc., Canada
Learn about current changes for drug safety professionals in their day-to-day practices. Topics discussed will include drug interchangeability, the evolving Biolsimilars landscape in Canada, and the upcoming changes in consumer product framework.
Speaker(s)
Drug Interchangeability – Understanding the Science and Navigating Forward
Yu Chung Tsang, PhD
Apotex Inc., Canada
Chief Science Officer, Biopharmaceuticals and Biostatistics, Apobiologix
The Consumer Health Product Framework
Kristin Willemsen, MS
Food, Health & Consumer Products of Canada, Canada
Vice President, Scientific & Regulatory Affairs
Second Entry Biologics
Colin D'Cunha, MD, MHS, FRCPC
Apotex Inc., Canada
Director, Global Medical Affairs
Have an account?